About us

Inmet S.A. is a pioneer biotechnological company from Argentina that develops genetically optimized microorganisms for the production of high-value compounds from low-cost feedstocks at the lowest environmental impact.

Inmet has implemented technological solutions that replace chemical products by biological ones, both sustainable and biodegradable.

Inmet started in 2011, as an initiative of researchers from IBR-CONICET, Diego de Mendoza and Gustavo Schujman, and INDEAR. Dr. Diego de Mendoza is Career Investigator from the National Research Council of Argentina (CONICET) and Professor Emeritus at the University of Rosario. He was co-founder and Director of the Institute of Molecular and Cellular Biology from Rosario (IBR). He was an International Scholar of the Howard Hughes Medical Institute (HHMI) and awarded the Guggenheim fellowship, the Humboldt Award from Alexander von Humboldt Foundation and the prize Investigator of the Argentine Nation granted by the President of Argentina. The research program carried out in the laboratory of Dr. de Mendoza centers on lipid metabolism in model organisms. In his laboratory were elucidated major signaling pathways controlling the overall rate and quality of fatty acid biosynthesis in the bacterium Bacilus subtilis, which are important to use this microorganism as a bio-factory of lipid-derived molecules. The laboratory also studies sterol metabolism in nematodes and its potential application in human health and agriculture.

Inmet promotes integration and collaborative work with private companies, universities, research institutes and the National government, to achieve economic development based on the knowledge derived from science and technology.

We provide state-of-art R&D Services in the field of bacterial Metabolic Engineering with the support of ultimate generation equipment and professional staff that contributes to an excellent technological advice to public and private institutions.

R&D – Products & Technologies

Biomaterials

Biofuel

Natural Preservatives

Biopesticides

Enzymes for Food Industry

Natural Anti-mycotic agent

Biomaterials

We genetically optimized fast growth innocuous bacteria to produce biodegradable polymers. We developed bacterial strains and processes for the bioconversion of agro-industrial feedstocks (raw glycerin, vinasses, etc.) into PHAs (poly-hydroxyalkanoates). These biopolymers are totally biodegradable, even in marine environment, with thermoplastic properties that vary according their chemical composition. Moreover, they are an efficient barrier against moisture, in contrast to starch-based bioplastic. Some of these polymers have similar physical properties to polypropylene.

Biofuel

We developed B. subtilis strains able to produce biofuel (biodiesel) from low-cost sources of carbon; an invention registered as a new patent. Currently, we are optimizing the biofuel yield in order to increase the bio-conversion, and to improve commercial profitability of the full project.

Natural Preservatives

We genetically optimized Bacillus subtilis strains for the production of biomolecules acting as anti-desiccation agent in a high-yield and low-cost system. They will be used initially as a preservation additive in packing products in the bio-inoculant industry. In a second stage production, will be directed to the cosmetic industry, as a component of humectant emulsions and protective lotions against UV radiation.

Biopesticides

In collaboration with a company from USA, which holds the patent of the first biological rodenticide, we are developing microbial production of its principal active substance. This project involves the characterization of the metabolic pathway in the original vegetal source and the expression of target genes in B. subtilis.

Enzymes for Food Industry

In cooperation with food companies, we are working in the production of enzymes widely used in food industry. We modified GRAS (Generally Recognized As Safe) organisms such as Bacillus subtilis and Pichia pastoris to express synthetic genes encoding fungal lipases, and optimized its production and purification.

Natural Anti-mycotic agent

In collaboration with SABERR S.R.L., we are optimizing Natamyicin production from bacterial strains that produce it naturally, and also from genetically engineered B. subtilis strains producing this anti-mycotic agent.

Contact Us

1 + 7 =

Inmet S.A.

+54 341 4861121 (Management)
+54 341 4861120 (Services)
Ocampo 210 bis, Predio CCT Rosario (2000) Rosario, Santa Fe, Argentina

For more information about our services or to set up an appointment in order to discuss your project of industrial residues bio-transformation, you do not hesitate in contacting us for any questions.